Personal information

No personal information available

Activities

Employment (1)

GETBO - UMR1304: BREST, FR

Engineer (Université de Bretagne Occidentale)
Employment
Source: Self-asserted source
Virginie Gourdou-Latyszenok

Works (11)

Extracellular RNA Induces Neutrophil Recruitment Via Toll‐Like Receptor 3 During Venous Thrombosis After Vascular Injury

Journal of the American Heart Association
2024-08-06 | Journal article
Contributors: Maria Y. Najem; Ryan N. Rys; Sandrine Laurance; François‐René Bertin; Virginie Gourdou‐Latyszenok; Lénaïck Gourhant; Lauriane Le Gall; Rozenn Le Corre; Francis Couturaud; Mark D. Blostein et al.
Source: check_circle
Crossref

TGFβ1 plasma levels and clot lysis assay to better characterize patients after a first unprovoked episode of pulmonary embolism

2024-05-16 | Preprint
Contributors: Marc Danguy des Deserts; Claire de Moreuil; Jamal Elhasnaoui; Lenaïck Gourhant; Virginie Gourdou-Latyszenok; Benjamin Espinasse; Juliette Menguy; Cécile Tromeur; Rozenn Le Corre; Raphael Le Mao et al.
Source: check_circle
Crossref

Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms

Journal of Thrombosis and Haemostasis
2024-01 | Journal article
Part of ISSN: 1538-7836
Contributors: Alexandre Guy; Geoffrey Garcia; Virginie Gourdou-Latyszenok; Laura Wolff-Trombini; Lara Josserand; Quentin Kimmerlin; Simon Favre; Badr Kilani; Caroline Marty; Yacine Boulaftali et al.
Source: Self-asserted source
Virginie Gourdou-Latyszenok

Endothelial Cell Phenotype, a Major Determinant of Venous Thrombo-Inflammation

Frontiers in Cardiovascular Medicine
2022-04-21 | Journal article
Part of ISSN: 2297-055X
Contributors: Marion Pilard; Estelle L. Ollivier; Virginie Gourdou-Latyszenok; Francis Couturaud; Catherine A. Lemarié
Source: Self-asserted source
Virginie Gourdou-Latyszenok

Description of a knock-in mouse model of JAK2V617F MPN emerging from a minority of mutated hematopoietic stem cells.

Blood
2019-12 | Journal article
Contributors: Mansier O; Kilani B; Guitart AV; Guy A; Gourdou-Latyszenok V; Marty C; Parrens M; Plo I; Vainchenker W; James C
Source: Self-asserted source
Virginie Gourdou-Latyszenok via Europe PubMed Central

High circulating levels of MPO-DNA are associated with thrombosis in patients with MPN.

Leukemia
2019-06 | Journal article
Contributors: Guy A; Favre S; Labrouche-Colomer S; Deloison L; Gourdou-Latyszenok V; Renault MA; Riviere E; James C
Source: Self-asserted source
Virginie Gourdou-Latyszenok via Europe PubMed Central

Comparison of endothelial promoter efficiency and specificity in mice reveals a subset of Pdgfb-positive hematopoietic cells.

Journal of thrombosis and haemostasis : JTH
2019-03 | Journal article
Contributors: Kilani B; Gourdou-Latyszenok V; Guy A; Bats ML; Peghaire C; Parrens M; Renault MA; Duplàa C; Villeval JL; Rautou PE et al.
Source: Self-asserted source
Virginie Gourdou-Latyszenok via Europe PubMed Central

Vascular endothelial cell expression of JAK2<sup>V617F</sup> is sufficient to promote a pro-thrombotic state due to increased P-selectin expression.

Haematologica
2018-08 | Journal article
Contributors: Guy A; Gourdou-Latyszenok V; Le Lay N; Peghaire C; Kilani B; Dias JV; Duplaa C; Renault MA; Denis C; Villeval JL et al.
Source: Self-asserted source
Virginie Gourdou-Latyszenok via Europe PubMed Central

TRO40303, a mitochondrial‐targeted cytoprotective compound, provides protection in hepatitis models

Pharmacology Research &amp; Perspectives
2015-06 | Journal article
Part of ISSN: 2052-1707
Part of ISSN: 2052-1707
Contributors: Sophie Schaller; Magali Michaud; Virginie Latyszenok; Fabrice Robert; Mélanie Hocine; Thomas Arnoux; Mélanie Gabriac; Hélène Codoul; Ahmed Bourhane; Isabel Clémançon de Bellefois et al.
Source: Self-asserted source
Virginie Gourdou-Latyszenok
grade
Preferred source (of 2)‎

Early deficits in glycolysis are specific to striatal neurons from a rat model of huntington disease.

PloS one
2013-11-26 | Journal article
Source: Self-asserted source
Virginie Gourdou-Latyszenok
grade
Preferred source (of 2)‎

Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model.

Neuropharmacology
2012-02-20 | Journal article
Source: Self-asserted source
Virginie Gourdou-Latyszenok
grade
Preferred source (of 2)‎